Intravitreal drug delivery systems for the treatment of ocular conditions
US10624904B2 · kind B2 · utility
1Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2016 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Jul 22, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M31/002
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure teaches precisely engineered biodegradable drug delivery systems and methods of making and utilizing such systems. In aspects, the biodegradable drug delivery systems taught herein comprise intravitreal ocular implants suitable for delivery of corticosteroids to the posterior segment of a human eye. The intravitreal ocular implants described herein have a desired extended drug release profile suitable for treating inflammation of the human eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.